Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant chemotherapy for osteosarcoma.

F R Eilber1, G Rosen

  • 1UCLA School of Medicine 90024.

Seminars in Oncology
|August 1, 1989
PubMed
Summary
This summary is machine-generated.

This review highlights key prognostic factors and effective chemotherapy for osteosarcoma. High-dose methotrexate, Adriamycin, and cisplatin combinations show promise, with neoadjuvant chemotherapy offering advantages in treatment and limb salvage surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and evaluation of obstructive sleep apnea prior to adenotonsillectomy in children: is there a problem?

Sleep medicine·2003
Same author

Evaluation of Attenuation Corrected Dual Head Coincidence Imaging (AC DHCI) in Detection of Intra-abdominal Tumors.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same author

Retroperitoneal sarcomas.

Current treatment options in oncology·2002
Same author

Distribution of androgen receptor mRNA expression and immunoreactivity in the brain of the green anole lizard.

Journal of neuroendocrinology·2002
Same author

Circadian rhythms and circadian rhythm disorders in children and adolescents.

Seminars in pediatric neurology·2002
Same author

Methadone is safe for treating hospitalized patients with severe pain.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2001
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Chemotherapy
  • Skeletal System Neoplasms

Background:

  • Osteosarcoma presents with diverse histologies and varying prognoses.
  • Prognostic indicators include tumor location, stage, patient age, and disease extent.
  • Effective treatment strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To review chemotherapy trials for osteosarcoma.
  • To identify important prognostic factors and effective chemotherapeutic agents.
  • To suggest clinical practice algorithms based on current evidence.

Main Methods:

  • Review of chemotherapy trials for osteosarcoma.
  • Analysis of prognostic factors influencing disease outcome.
  • Evaluation of the efficacy of various chemotherapeutic agents and combinations.

Related Experiment Videos

Main Results:

  • Prognostic factors: tumor location, stage, age, and extremity site impact outcomes.
  • Effective agents: high-dose methotrexate, Adriamycin, and cisplatin demonstrate efficacy.
  • Combination therapy: Adriamycin and cisplatin combination appears superior to monotherapy.
  • Neoadjuvant chemotherapy: offers advantages in treatment assessment and limb-sparing surgery.

Conclusions:

  • Chemotherapy is indicated for all osteosarcoma patients.
  • Essential chemotherapy regimen includes high-dose methotrexate, Adriamycin, and cisplatin.
  • Neoadjuvant chemotherapy provides significant benefits, including potential for limb salvage.
  • Close patient follow-up is essential for therapeutic value.